Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-612-5 | CAS number: 97-85-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
- Specific details on test material used for the study:
- The test substance is identified as Isobutyl isobutyrate. The purity is 98.99%. The physical state/appearance of material is clear colourless liquidwhite solid. The expiry date of material is 6 February 2018. The substance can be stored at room temperature in the dark conditions.
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Female Wistar (RccHanTM :WIST) strain rats were supplied by Envigo RMS (UK) Limited, Oxon, UK.The females were nulliparous and non-pregnant. After an acclimatization period of at least 5 days the animals were selected at random and given a number unique within the study by indelible ink-marking on the tail and a number written on a cage card. At the start of the study the animals were 8 to 12 weeks of age. The body weight variation did not exceed of the mean body weight at the start of treatment.
The temperature and relative humidity were set to achieve limits of 19 to 25 o c and 30 to 70% respectively. The rate of air exchange was at least fifteen changes per hour and the lighting was controlled by a time switch to give 12 hours continuous light and 12 hours darkness. - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- All animals were dosed once only by gavage, using a metal cannula attached to a graduated syringe. The volume administered to each animal was calculated according to the fasted body weight at the time of dosing. Treatment of animals was sequential. Sufficient time was allowed between each dose group to confirm the survival of the previously dosed animals.
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- A total of five animals were therefore treated at a dose level of 2000 mg/kg in the study.
- Details on study design:
- All animals were dosed once only by gavage, using a metal cannula attached to a graduated syringe. The volume administered to each animal was calculated according to the fasted body weight at the time of dosing. Treatment of animals was sequential. Sufficient time was allowed between each dose group to confirm the survival of the previously dosed animals. Clinical observations were made 30 minutes, 1, 2, and 4 hours after dosing and then daily for 14 days. Morbidity and mortality checks were made twice daily, early and late during normal working days, and once daily at weekends and public holidays. Individual body weights were recorded on Day 0 (the day of dosing) and on Days 7 and 14. At the end of the observation period the animals were killed by cervical dislocation. All animals were subjected to gross necropsy. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths
- Clinical signs:
- other: There were no cllinical observations.
- Gross pathology:
- No abnormalities were noted at necropsy.
- Interpretation of results:
- other: Globally Harmonized Classification System — Unclassified
- Conclusions:
- The acute oral median lethal dose (LD50) of the test item in the female Wistar strain rat was estimated to be greater than 2000 mg/kg body weight (Globally Harmonized Classification System — Unclassified).
- Executive summary:
The study was performed to assess the acute oral toxicity of the Isobutyl isobutyrate in the Wistar strain rat.
In the absence of toxicity at a dose level of 2000 mg/kg in one animals, an additional group of animals was treated with 2000 mg/kg dose level. A total of five animals were therefore treated at a dose level of 2000 mg/kg in the study. Clinical signs and body weight development were monitored during the study. All animals were subjected to gross necropsy. There were no deaths observed during the test. There were no signs of systemic toxicity. All animals showed expected gains in body weight. No abnormalities were noted at necropsy.The acute oral median lethal dose (LD50) of the test item in the female Wistar strain rat was estimated to be greater than 2000 mg/kg body weight (Globally Harmonized Classification System — Unclassified).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- The study was conducted well before GLP or OECD guidelines. Documentation is very limited, but the study was conducted at a leading laboratory to the state of the art at the time.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- no
- Test type:
- other:
- Limit test:
- no
- Species:
- rat
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Duration of exposure:
- 6 h
- Concentrations:
- 3.88 or 31.94 mg/l
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- Test subjects were exposed to either 3.88 or 31.94 mg/l for 6 hours and then monitored for 2 weeks.
- Dose descriptor:
- LC50
- Effect level:
- > 3.88 - < 39.14 mg/L air
- Based on:
- test mat.
- Mortality:
- 2/3 dead at 39.14 mg/l, no deaths at 3.88 mg/l
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- There were 2/3 dead at 39.14 mg/l, no animals were found dead at 3.88 mg/l.
- Executive summary:
The LC50 was between 3.88 and 39.14 mg/l.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- The study was conducted well before GLP or OECD guidelines. Documentation is very limited, but the study was conducted at a leading laboratory to the state of the art at the time.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Test type:
- other:
- Limit test:
- no
- Species:
- guinea pig
- Type of coverage:
- occlusive
- Details on dermal exposure:
- IBIB was applied to skin under a gauze pad and occlusive covering with a rubber cuff.
- Duration of exposure:
- 24 hours
- Doses:
- 5 or 10 cc/kg
- Details on study design:
- The test article was applied for 24 hours under an occlusive rubber cuff. After removal the test subjects were observed for 2 weeks.
- Dose descriptor:
- LD50
- Effect level:
- > 10 other: cc/kg
- Based on:
- test mat.
- Mortality:
- none
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD50 was > 10 cc/kg
- Executive summary:
The dermal LD50 was > 10 cc/kg
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 10 000 mg/kg bw
Additional information
Justification for classification or non-classification
Classification is not appropriate as an LD50 was not reached in either oral or dermal toxicity testing
One supporting acute oral study and one key acute oral study following OECD TG 420 under GLP conditions were available for isobutyl isobutyrate (IBIB). In supporting study, the rats were dosed at concentrations ranging from 200 to 12,800 mg/kg and monitored for 2 weeks. The LD50 was determined between 6400 and 12800 mg/kg. In the key study, rats were treated with 2000 mg/kg dose level. There were no deaths observed during the test. There were no signs of systemic toxicity. All animals showed expected gains in body weight. No abnormalities were noted at necropsy. The acute oral median lethal dose (LD50) of the test item in the female Wistar strain rat was estimated to be greater than 2000 mg/kg body weight. Similarly, in an acute dermal study, no mortality was observed when guinea pigs were treated with IBIB dermally. Inhalation (2 reliability) study gave LC50 value between 3.88 and 39.14 mg/l in rats. IBIB is not classified under Globally Harmonized Classification System (Unclassified) in acute studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.